Significance of Genetic Polymorphisms at Multiple Loci of CYP2E1 in the Risk of Development of Childhood Acute Lymphoblastic Leukemia

Background/Aims: The molecular etiology of childhood acute lymphoblastic leukemia (ALL) is likely to involve interactions between environmental factors and genetic make up. Understanding these interactions between various predisposing genes for the risk of developing childhood leukemia is of considerable importance. CYP2E1 is a susceptible gene in this respect, especially for its capacity to bioactivate many procarcinogens including benzene and N-nitrosodimethylamine. The CYP2E1 gene possesses several polymorphisms in humans, and among them, CYP2E1*5B and *6 have been shown to be associated with increased risks of several chemical-induced diseases. There are limited and contradictory data on the association between the CYP2E1*5B variant allele and childhood ALL, and none on such associations of CYP2E1*6 and*7B variant alleles. The aim of this study was to investigate the possible association of CYP2E1*5B, *6 and *7B alleles, alone or in combination, with the risk of incidence of childhood ALL in a Turkish population. Methods: The genotypes for both polymorphisms were determined by polymerase chain reaction/restriction fragment length polymorphism techniques on 207 healthy controls and 168 patients. Results: Neither locus was associated with the occurrence of childhood ALL. On the other hand, when both CYP2E1*5B and *6 alleles were considered together, the risk of childhood ALL increased significantly (2.9-fold; OR = 2.9, 95% CI 1.0–8.5; p < 0.05). Moreover, the presence of at least 2 variant alleles of any combination increased the risk significantly 3.9 times, suggesting a combined effect (OR = 3.9, 95% CI 1.4–11.0). Conclusion: Individuals carrying combinations of CYP2E1*5B, *6 and *7B variants together are likely associated with the risk of developing childhood ALL.

[1]  O. Adalı,et al.  Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population , 2007, Archives of Toxicology.

[2]  Ş. Arslan,et al.  Effects of diabetes on rabbit kidney and lung CYP2E1 and CYP2B4 expression and drug metabolism and potentiation of carcinogenic activity of N-nitrosodimethylamine in kidney and lung. , 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[3]  S. Pakakasama,et al.  Polymorphisms of drug‐metabolizing enzymes and risk of childhood acute lymphoblastic leukemia , 2005, American journal of hematology.

[4]  D. Ross Functions and distribution of NQO1 in human bone marrow: potential clues to benzene toxicity. , 2005, Chemico-biological interactions.

[5]  Ş. Arslan,et al.  Differential effects of diabetes on CYP2E1 and CYP2B4 proteins and associated drug metabolizing enzyme activities in rabbit liver , 2005, Archives of Toxicology.

[6]  J. Downing,et al.  Satelite Symposium V, Meet-the-Professor Sessions I and II, Main Sessions I-IX , 2004, Annals of Hematology.

[7]  C. Takahashi,et al.  Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia , 2004, Environmental and molecular mutagenesis.

[8]  Ricarda Thier,et al.  The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine , 2003, International archives of occupational and environmental health.

[9]  D. Labuda,et al.  Childhood Acute Lymphoblastic Leukemia Associated with Parental Alcohol Consumption and Polymorphisms of Carcinogen-Metabolizing Genes , 2002, Epidemiology.

[10]  D. Labuda,et al.  Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  D. Labuda,et al.  Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia , 2002, International journal of cancer.

[12]  P. Vineis,et al.  Metabolic gene polymorphism frequencies in control populations. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[13]  A. Tates,et al.  Association between genetic polymorphisms and biomarkers in styrene-exposed workers. , 2001, Mutation research.

[14]  J. Y. Park,et al.  Elucidation of CYP2E1 5' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer. , 2001, Oral oncology.

[15]  N. Kongruttanachok,et al.  Cytochrome P450 2E1 polymorphism and nasopharyngeal carcinoma development in Thailand: a correlative study , 2001, BMC Cancer.

[16]  A. Demaine,et al.  Study of polymorphisms in the CYP2E1 gene in patients with alcoholic pancreatitis. , 2001, Alcohol.

[17]  O. Adalı,et al.  Stimulation of aniline, p-nitrophenol and N-nitrosodimethylamine metabolism in kidney by pyridine pretreatment of rabbits , 2000, Archives of Toxicology.

[18]  O. Adalı,et al.  Induction of N-nitrosodimethylamine metabolism in liver and lung by in vivo pyridine treatments of rabbits , 2000, Archives of Toxicology.

[19]  I. de Waziers,et al.  Detection and characterization of novel polymorphisms in the CYP2E1 gene. , 1998, Pharmacogenetics.

[20]  L. Marchand,et al.  Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. , 1998, Cancer research.

[21]  D. Lin,et al.  Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1, and M1 and cytochrome P450 2E1. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[22]  J. Haerting,et al.  Impact of CYP2E1 genotype in renal cell and urothelial cancer patients. , 1998, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[23]  M. Spitz,et al.  Cytochrome P450 2E1 DraI polymorphisms in lung cancer in minority populations. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[24]  S. Z. Abdel‐Rahman,et al.  Combined genetic polymorphism and risk for development of lung cancer. , 1997, Mutation research.

[25]  C. Lieber,et al.  Cytochrome P-4502E1: its physiological and pathological role. , 1997, Physiological reviews.

[26]  E. Bowman,et al.  A cytochrome P4502E1 genetic polymorphism and tobacco smoking in breast cancer , 1996, Molecular carcinogenesis.

[27]  D W Nebert,et al.  Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer. , 1996, DNA and cell biology.

[28]  E. Kharasch,et al.  Identification of Cytochrome P450 2E1 as the Predominant Enzyme Catalyzing Human Liver Microsomal Defluorination of Sevoflurane, Isoflurane, and Methoxyflurane , 1993, Anesthesiology.

[29]  K. Kawajiri,et al.  Genetic Polymorphisms in the 5 '-Flanking Region Change Transcriptional Regulation of the Human Cytochrome P 45011 E 1 Gene ' , 2008 .

[30]  F. Guengerich,et al.  Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. , 1991, Chemical research in toxicology.

[31]  M. Ingelman-Sundberg,et al.  Benzene metabolism by ethanol-, acetone-, and benzene-inducible cytochrome P-450 (IIE1) in rat and rabbit liver microsomes. , 1988, Cancer research.

[32]  F. Gonzalez,et al.  Stabilization of cytochrome P450j messenger ribonucleic acid in the diabetic rat. , 1987, Molecular endocrinology.

[33]  F. Gonzalez,et al.  The induction of a specific form of cytochrome P-450 (P-450j) by fasting. , 1987, Biochemical and biophysical research communications.

[34]  J. Casazza,et al.  Identification of ethanol-inducible P-450 isozyme 3a as the acetone and acetol monooxygenase of rabbit microsomes. , 1985, The Journal of biological chemistry.

[35]  E. Arinç,et al.  Preparation and properties of partially purified pulmonary cytochrome P-450 from rabbits. , 1976, The Journal of biological chemistry.